Acupuncture for the Treatment of Hot Flashes in Breast Cancer Patients: A Randomized Controlled Trial
- Determine whether acupuncture, compared to placebo, reduces the incidence of hot
flashes in women with breast cancer.
- Determine the long-term effects of acupuncture on hot flashes.
OUTLINE: This a randomized, placebo-controlled, multicenter study. Patients are stratified
according to concurrent treatment with selective estrogen receptor modulators,
gonadotropin-releasing hormone analogs, or aromatase inhibitors (yes vs no), concurrent use
of hot flash medication or selective serotonin reuptake inhibitors (SSRIs) (yes vs no),
baseline hot flash frequency (> 7 per day), and menopausal status at diagnosis
(premenopausal vs postmenopausal). Patients are randomized to 1 of 2 treatment arms.
- Arm I (treatment): Patients receive 8 acupuncture treatments over 4 weeks.
- Arm II (control): Patients receive 8 placebo acupuncture treatments over 4 weeks.
Beginning at week 7, patients are offered 8 true acupuncture treatments over 4 weeks.
Patients in both arms complete a "hot flash" diary for 1 week before treatment and then
periodically during and after treatment.
After completion of study treatment, patients are followed periodically.
PROJECTED ACCRUAL: A total of 80 patients will be accrued for this study.
Allocation: Randomized, Primary Purpose: Supportive Care
Frequency and severity of hot flashes, as measured by a hot flash diary
Barrie R. Cassileth, PhD
Memorial Sloan-Kettering Cancer Center
United States: Institutional Review Board
|Memorial Sloan-Kettering Cancer Center||New York, New York 10021|